| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/18/2009 | CN101370791A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370790A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370789A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370788A Morpholino pyrimidine derivatives and their use in therapy |
| 02/18/2009 | CN101370501A Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 02/18/2009 | CN101367769A N-(2-pyrimidine oxygen based) benzyl amide compounds, preparation method and uses thereof |
| 02/18/2009 | CN101367768A N-(2-pyrimidine oxygen based)benzyl sulfonylamines compounds, preparation method and uses thereof |
| 02/18/2009 | CN101367767A Room temperature solvent-free synthesis of 3,4-dihydropyrimidine-2-ketone |
| 02/18/2009 | CN101367766A (2-pyrimidine oxygen base)benzaldehyde hydrazone compounds, preparation method and uses thereof |
| 02/18/2009 | CN101367749A A set of mesidino mesitoyl derivant, preparation and application thereof |
| 02/17/2009 | US7491827 Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
| 02/17/2009 | US7491822 Production method of aminopyrimidine compound |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491732 Compositions and methods for inhibition of the JAK pathway |
| 02/17/2009 | US7491731 Crystal structure of liganded cFMS kinase domain |
| 02/17/2009 | US7491729 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 02/17/2009 | US7491728 Pyrimidinone compounds as calcilytics |
| 02/17/2009 | US7491727 Arylpiperazinyl compounds |
| 02/12/2009 | WO2009019901A1 Novel nucleic acid derivative into which given compound has been introduced and method for producing the same |
| 02/12/2009 | WO2009019661A1 Process for preparation of amorphous lopinavir |
| 02/12/2009 | WO2009019211A1 Process for the preparation of methyl ester of rosuvastatin |
| 02/12/2009 | WO2009019167A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 02/12/2009 | US20090043098 Method for Preparation of Optionally 2-Substituted 1,6-Dihydro-6-Oxo-4-Pyrimidinecarboxylic Acids |
| 02/12/2009 | US20090043096 Method of producing aromatic compound |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042900 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090041786 e.g. 5-Fluoro-N4-(3-hydroxyphenyl)-N2-[4-(N-methyl)aminosulfonyl-3-methoxyphenyl]-2,4-pyrimidinediamine; tyrosine (JAK) kinases inhibitor; interleukin and tumor necrosis factor ligand; transplant rejection; T-cell mediated autoimmune disease |
| 02/12/2009 | CA2696565A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 02/12/2009 | CA2685002A1 Quinazoline compounds |
| 02/11/2009 | EP2022785A1 Alkynylpyrimidines as Tie2 kinase inhibitors |
| 02/11/2009 | EP2022784A1 Process for the preparation of methyl ester of rosuvastatin |
| 02/11/2009 | EP2022500A1 Tumor suppressor |
| 02/11/2009 | EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 02/11/2009 | EP2021019A2 Identification of cdki pathway inhibitors |
| 02/11/2009 | CN101365686A Heterocyclic derivatives as modulators of ion channels |
| 02/11/2009 | CN101365681A Iminopropene compound and use thereof |
| 02/11/2009 | CN101362723A 2,4-diamino quinazolines compounds and synthesis method thereof |
| 02/11/2009 | CN100460412C Process for preparing amine platinum complexes |
| 02/10/2009 | US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory |
| 02/10/2009 | US7488733 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
| 02/10/2009 | US7488732 2-substituted pyrimidines |
| 02/10/2009 | US7488731 Arylpiperazinyl compounds |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/10/2009 | CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/05/2009 | WO2009017777A2 Metabolites and derivatives of ambrisentan |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009015877A1 Novel herbicides |
| 02/05/2009 | WO2008125691A3 Ethers of naphtalene carboxylic acid amides as cancer cure |
| 02/05/2009 | US20090036680 Salts of hmg-coa reductase inhibitors and use thereof |
| 02/05/2009 | US20090036676 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 02/05/2009 | US20090036473 Novel quinazolinone derivatives and their medical use |
| 02/05/2009 | US20090036470 Paliperidone derivatives |
| 02/05/2009 | US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | CA2695259A1 Metabolites and derivatives of ambrisentan |
| 02/05/2009 | CA2693190A1 Novel herbicides |
| 02/04/2009 | CN101360738A Compositions and methods for modulating gated ion channels |
| 02/04/2009 | CN101360723A Process for the preparation of pyrimidinedione derivatives |
| 02/04/2009 | CN101360722A Novel 2-aminopyrimidine derivatives and their use |
| 02/04/2009 | CN101360721A Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 02/04/2009 | CN101360720A Novel 2-aminopyrimidinone derivatives and their use |
| 02/04/2009 | CN101360719A 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 02/04/2009 | CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 02/04/2009 | CN101357905A Method for preparing 4-[3-chloro-4-(3-fluoro-benzyloxy)-anilino]-6-substituted amido-quinazoline derivative |
| 02/04/2009 | CN101357904A 2-phenyl-4,6-dichloro pyrimidine preparation method |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2327635C Uracil compounds and use thereof |
| 01/29/2009 | WO2009015369A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 01/29/2009 | WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 01/29/2009 | WO2009012702A1 Use of 4-aniline quinazoline derivative for preparing medicaments |
| 01/29/2009 | WO2009012650A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/29/2009 | WO2008116339A3 Organic compounds |
| 01/29/2009 | WO2008107211A3 Novel p2y12 receptor antagonists |
| 01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof |
| 01/29/2009 | US20090030009 Heterobicyclic Carboxamides as Inhibitors for Kinases |
| 01/29/2009 | US20090030008 Piperazine derivatives and their use as therapeutic agents |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
| 01/29/2009 | CA2694275A1 Organic compounds |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/28/2009 | EP2018853A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 01/28/2009 | CN101356163A Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 01/28/2009 | CN101356160A Trisubstituted quinazolinone derivatives as vanilloid antagonists |